Complex Ocular Infection, Optimization of Microbiological Diagnosis
ICODIA
2 other identifiers
observational
153
1 country
1
Brief Summary
The purpose of this study is to evaluate the impact of different technique to optimize the microbiological diagnosis of the COI.
- Metagenomic for the endophtalmitis
- Multiplex polymerase chain reaction for corneal abscesses
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2022
CompletedFirst Posted
Study publicly available on registry
June 27, 2022
CompletedStudy Start
First participant enrolled
November 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedSeptember 15, 2025
September 1, 2025
1.7 years
May 12, 2022
September 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positivity rates of COI samples according to the new protocol
Before/after type comparison. Comparison of the positivity rates of COI samples according to the new protocol: (i) for endophthalmitis performing a vitreous puncture (PV) or an anterior chamber puncture (PCA), or corneal scraping, optimized with modification of microbiological techniques (culture on enriched medium alone associated with shotgun metagenomics), (ii) for severe corneal abscesses, addition to standard microbiological techniques of molecular biology tests (multiplex PCR and / or metagenomics). An COI will be considered with a positive microbiological diagnosis after multidisciplinary concertation considering the different results
2 weeks after taking samples
Secondary Outcomes (6)
Microbiological diagnosis of the infection
At the end of the follow up: 18 months
Time to microbiological diagnosis according to the different technic
At the end of the follow up: 18 months
Accuracy of the different technics according to the gold standard (microbiological culture)
At the end of the follow up: 18 months
Visual acuity
At the end of the follow up: 18 months
Cure rate
At the end of the follow up: 18 months
- +1 more secondary outcomes
Study Arms (1)
Complex ocular infections (COI)
All patients with an COI (endophtalmitis or hospitalized keratitis)
Interventions
For endophtalmitis : optimizing culture and NGS will be realized For keratitis: Multiplex PCR will be added on ocular samples
Eligibility Criteria
Patient presenting or having presented a clinical suspicion of complex ocular infection requiring a sample for microbiological diagnosis
You may qualify if:
- Adult patient
- Patient presenting or having presented a clinical suspicion of complex ocular infection requiring a sample for microbiological diagnosis:
- Corneal abscess requiring hospitalization
- Any suspicion of endogenous or exogenous endophthalmitis.
- Patient not opposed to participating in the research
You may not qualify if:
- Patient under guardianship or curatorship
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Equipe mobile d'infectiologie, Cochin hospital
Paris, IDF, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Etienne CANOUI, MD
Assistance Publique - Hôpitaux de Paris
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2022
First Posted
June 27, 2022
Study Start
November 21, 2023
Primary Completion
July 17, 2025
Study Completion
January 1, 2026
Last Updated
September 15, 2025
Record last verified: 2025-09